Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – Commission launches a public consultation and a call for evidence for EU...

The Commission has launched a public consultation and a call for evidence on the EU’s legislation on medical devices and in vitro diagnostic medical devices, as...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical Devices Regulatory Reform – Roadmap to implementation – Update

A roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices and an intended policy on international recognition...

Europe – MDCG 2024-16: Manufacturer Information Form on Interruption or Discontinuation of Supply of...

The Medical Device Coordination Group (MDCG) has introduced new guidance under MDCG 2024-16, streamlining how manufacturers report interruptions or discontinuations in the supply of...

USA – Final FDA guidance on PCCP includes clarification on version control

The US Food and Drug Administration (FDA) has finalized a long-anticipated guidance on using predetermined change control plans (PCCPs) in submissions for medical devices...

USA – FDA finalizes guidance on 510(k) third-party reviews

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) on Thursday finalized guidance to assist manufacturers in using an...

USA – The regulatory landscape of ingestible medical devices in the United States

Ingestible medical devices offer novel diagnostic, monitoring, and treatment capabilities. This article explores the regulatory landscape of ingestible devices in the US, highlighting the...

USA – Data Normalization Challenges and Mitigations in Software Bill of Materials (SBOM) Processing:...

The Mitre Corporation says stakeholders should work together to normalize how software bill of materials (SBOMs) are implemented in a newly published white paper,...
Statement on the Investigational Use of Marketed Drugs in Clinical Trials

Canada – Health Canada digital health head says AI/ML guidance imminent

Health Canada is very close to publishing a much-anticipated guidance on artificial intelligence/machine learning (AI/ML) medical devices and has incorporated pre-determined change control plans...

USA – FDA names new head of medical device evaluation and quality

The Food and Drug Administration named Ross Segan as director of the medical device center’s Office of Product Evaluation and Quality (OPEQ), following a...

USA – FDA releases three post-pilot ASCA draft guidances

The US Food and Drug Administration (FDA) has issued its first set of draft guidance documents for the full-fledged Accreditation Scheme for Conformity Assessment...

NOS PROCHAINES FORMATIONS